Cardiogenic shock cost-effectiveness of therapy
|
Cardiogenic Shock Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiogenic shock cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Cardiogenic shock cost-effectiveness of therapy |
|
Risk calculators and risk factors for Cardiogenic shock cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
Cost-Effectiveness
Attending to the fact that cardiogenic shock is a lethal condition, with a high mortality rate, if not diagnosed early and treatment started in the shortest time-span possible, an aggressive diagnostic and therapeutic approach are of uttermost importance, therefore justifying the costs involved in the procedures. An evidence of the effectiveness of timely and adequate diagnosis and treatment of cardiogenic shock is the fact that from 1975 to 1990, the in-hospital mortality from this condition averaged 77%. Between 1993 and 1995 this percentage declined to 61%, reaching about 59% in 1997. This decrease was greatly due to the innovative revascularization techniques along with the aggressive approach to shock seen during this period.[1][2]
References
- ↑ Goldberg, Robert J.; Samad, Navid A.; Yarzebski, Jorge; Gurwitz, Jerry; Bigelow, Carol; Gore, Joel M. (1999). "Temporal Trends in Cardiogenic Shock Complicating Acute Myocardial Infarction". New England Journal of Medicine. 340 (15): 1162–1168. doi:10.1056/NEJM199904153401504. ISSN 0028-4793.
- ↑ Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD; et al. (1999). "Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock". N Engl J Med. 341 (9): 625–34. doi:10.1056/NEJM199908263410901. PMID 10460813.